NCCBA Seminar: Bio-Pharmaceutical Opportunities in China

(Presented in English)

Due to the high skyrocketing new drug development costs, low productivity and drug pricing pressure, global pharmaceutical and biotech companies are turning to China and India to conduct lower-cost R & D. The costs for new drug development in Asia are generally much lower that that in the US and Europe. For instance, the average cost for pre-clinical development in China is only 20% of that in the U.S. The fast growing economy, reformed healthcare system, the large population and a rapidly aging population in China, and coupling with recently built and upgraded pharmaceutical and biotech facilities, increased experienced clinical trial sites, and greatly improved understanding of GLP, GCP and GMP procedures, as well as the retuning of a large number of overseas well educated, trained technical and professional people are the largest drives for the consideration of conducting new drug R & D in China. With current difficulty in raising traditional funds for a start-up or developing stage mid and small pharmaceutical and biotech companies who have early stage drug development programs, low cost considerations are even more critical for business development and growth. In this presentation I will discuss my personal observations how Chinese pharmaceutical and biotech industry has rapidly transformed into a major global player of pharmaceutical R & D recently and provided vast opportunities for ventures and new business opportunities in China. I will present you some pro and con in outsourcing of pharmaceutical R & D to China and the business opportunities in China.

Speaker: Dr. Ken Chang, bio:

Dr. Chang was the founder, the President, CEO and Chairman of the Board of former Ardent Pharmaceuticals, Inc., Durham, North Carolina. He has raised approximately $35 million since the inception of Ardent Pharmaceuticals in 1995. Ardent Pharmaceuticals, Inc. was recently merged with Enhance Biotech, Inc., a public company. Dr. Chang’s new title for the Enhance Biotech, Inc. is the Chief Scientific Officer and President Asia-Pacific Operations. He currently holds an Adjunct Professor appointment in the Department of Anesthesiology, Duke University Medical Center, Durham, North Carolina. He was a Principal Scientist at former Burroughs Wellcome Co. He is the co-inventor for 8 issued US patents and 8 pending US patents. Dr. Chang has published approximately 200 papers. He is a co-editor of the book entitled “The Delta Receptor” published by Marcel Dekker, Inc. in 2004. He is an internationally recognized expert in receptor pharmacology, biochemistry and molecular biology. He pioneered in the discovery of delta receptors, delta receptor-selective compounds and the understanding of physiological functions of the delta receptors. Dr. Chang received his Bachelor of Science degree in Pharmacy from the School of Pharmacy, National Taiwan University in Taipei, Taiwan and his Ph.D. degree in Biochemical Pharmacology from the State University of New York at Buffalo, and his postdoctoral training in Medical School, Johns Hopkins University.

Cost: FREE for NCCBA Regular members. You can join NCCBA and become a member at this seminar. $10 suggested donation for non-members if you feel like the seminar is beneficial to you. Donation will be used for covering drink, snacks and other cost associated to seminars.

When: 7:00-9:00 pm, Saturday, September 10, 2005. We will have half-hour of networking social before (starting 6:30pm) and after the seminar. Come early to meet your old and new friends.


MCNC, MCNC Auditorium

Building #1

3021 Cornwallis Road,

Research Triangle Park, NC 27709-2889


Map and Directions:

Driving Directions:

1. Directions from Raleigh or locations south or east of RTP. (Please reference Map:

Take I-40 West, toward Chapel Hill/Durham. Take the Durham Freeway (Route 147) North, the sign reads "Exit #279B, 147 North, Durham." Take the next exit (to the right) marked "Research Triangle Park, Cornwallis Road." At the end of the exit, turn right onto Cornwallis Road. Continue after the first light (entrances to GlaxoSmithKline to both the right and left)for about 0.2 miles - the sign of the entrance to MCNC is on the right-hand side. The MCNC auditorium is next to the front entrance of the building.

2. Directions from Durham, Chapel Hill, or locations north or west of RTP: (Please reference Map:

Take I-85 to the Durham Freeway (Route 147). Take the Durham Freeway (Route 147) South to the Cornwallis Road Exit. At the end of the ramp, make right turn on to Cornwallis Road. Go through the first light if it was not red (entrances to GlaxoSmithKline to both the right and left), and continue for about 0.2 miles - the entrance to MCNC is on the right-hand side, just after the yellow "Signal Ahead" sign.The MCNC auditorium is next to the front entrance of the building.

*********************About NCCBA**********************

North Carolina Chinese Business Association (NCCBA: is a premier nonprofit charitable and educational business organization. NCCBA’s mission is to represent, serve, and promote the common interests of our membership and the North Carolina Chinese business community, particularly in promoting entrepreneurial and corporate development related to sciences and technologies. NCCBA will serve as a forum for networking and exchanging, for advancing our knowledge in creating and sustaining successful businesses, and for encouraging and facilitating coaching and consultation among our members. NCCBA will also serve as a major catalyst in bridging the China - North Carolina business relationship.

*****************NCCBA Membership*******************

Per requests, NCCBA will accept membership application on the site before and after the seminar. We encourage professionals and entrepreneurs to join this exciting non-profit organization. You will be invited to members-only networking social events, receptions and seminars among many other benefits. Please call (919) 345-6294 or (919) 481-3038 if you have any question on membership. More information about NCCBA is available at